Building A Strong Safety Culture In The Biopharmaceutical Industry

Safety culture is a cornerstone of operational excellence in the biopharmaceutical and biotechnology industries. It reflects a "culture of accountability" that integrates proactive risk management, continuous improvement, and a shared commitment to safety across all levels of an organization. Moving beyond reactive lagging indicators to proactive leading indicators enables forward-looking strategies that enhance worker well-being and product quality.

In this segment, Dr. AJ Troiano, a registered biosafety professional and global director of Biosafety and Toxicology at FUJIFILM Diosynth Biotechnologies, shares that leadership engagement, cross-departmental collaboration, and effective communication are vital to embedding safety into an organization’s culture. Leaders drive data-driven decision-making and advocate for safety initiatives, ensuring alignment with operational goals. Transparent safety programs, supported by metrics, foster trust and improvement, particularly within multinational organizations like FUJIFILM Diosynth Biotechnologies.

Proactive efforts include pragmatic risk assessments, especially for novel biologics with limited long-term data. Balancing efficiency with safety, leveraging data for resources, and maintaining transparent, positive communication is key to building trust and reinforcing safety’s value. Recognizing achievements and learning from successes and failures strengthen engagement and safety outcomes.

Watch the full video below to learn why a strong safety culture will prioritize accountability, foster collaboration, and integrate safety as a core organizational value, to drive operational excellence and long-term success.